DEF 14A: TerrAscend Corp. Announces Annual Shareholder Meeting to Vote on Director Elections and Stock Option Amendments

TerrAscend Corp. will hold its annual shareholder meeting virtually on June 17, 2024, to vote on the election of directors, ratification of the auditor, and approval of amendments to stock options held by certain insiders.

Summary

• TerrAscend Corp. will hold its annual meeting of shareholders virtually on June 17, 2024, at 1:00 p.m. (Eastern Time).
• Shareholders will vote on several key proposals, including the election of five director nominees, the ratification of MNP LLP as the independent public accounting firm for the fiscal year ending December 31, 2024, and the approval of amendments to extend the expiry dates of 1,250,000 stock options held by certain insiders to 10 years from their grant dates.
• The record date for determining shareholders entitled to vote at the meeting was April 24, 2024.
• Shareholders can attend, participate, and vote at the meeting online, with specific instructions provided for registered shareholders and duly appointed proxyholders.
• The Corporation is providing meeting-related materials to Shareholders over the Internet rather than in paper form.
• The Corporation's registered and head office is located at 77 City Centre Drive, East Tower Suite 501, Mississauga, Ontario L5B 1M5.
• As of April 24, 2024, there were 291,507,430 Common Shares, no Proportionate Voting Shares, 63,492,037 Exchangeable Shares and 12,950 Preferred Shares issued and outstanding.
• Jason Wild directly and indirectly controls 90,402,715 Common Shares representing 31.01% of the Common Shares as of the Record Date.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral tone. The positive aspects include the company's efforts to engage with shareholders and maintain corporate governance standards. The risks associated with the cannabis industry temper the overall sentiment.

Positives

• The company is providing shareholders with multiple avenues to participate in the annual meeting, including virtual attendance and proxy voting.
• The board is recommending shareholders vote in favor of all proposals, including the election of directors, ratification of the auditor, and the stock option extension resolution.
• The company has a lead independent director, Craig Collard, to help reinforce the independence of the Board as a whole.
• The Corporation has two women directors (representing 40% of the Board).

Negatives

• The meeting is being held virtually, which may limit some shareholders' ability to participate fully.
• The proposal to extend stock options benefits certain insiders, which could be viewed negatively by some shareholders if they feel it is not in the best interest of all shareholders.
• Mr. Ed Schutter is not an independent director as he is the former Chief Executive Officer of Arbor Pharmaceuticals, a privately held company in respect of which Mr. Wild was also a director and served as a member of the Arbor Pharmaceuticals compensation committee (although this is no longer the case given the sale of Arbor Pharmaceuticals in September 2021; Mr. Wild and Mr. Schutter are no longer involved with Arbor Pharmaceuticals).
• The Corporation currently has three woman officer (representing 30% of the executive officers of the Corporation, including major subsidiaries of the Corporation).

Risks

• The cannabis industry faces significant legal restrictions and regulations in the United States, as cannabis remains a Schedule I drug under federal law.
• Enforcement of federal laws in the United States poses a significant risk to the business of the Corporation, and any proceedings brought against the Corporation thereunder may adversely affect its operations and financial performance.
• The Corporation is subject to risks associated with the cannabis industry in the United States.
• The Corporation is currently in the process of evaluating its corporate governance practices in light of the uplisting and recommended governance practices for non-venture issuers, such as the Corporation.

Future Outlook

The document outlines shareholder proposal deadlines for the 2025 annual meeting.

Industry Context

The document highlights the legal and regulatory challenges faced by cannabis companies operating in the United States, which is a common issue in the industry.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• However, the discussion of corporate governance practices and executive compensation aligns with typical disclosures in proxy statements of publicly traded companies.
• The audit fee disclosure is standard practice, but without knowing the company's revenue and complexity, it's difficult to assess whether the fees are in line with industry benchmarks.
• Comparing TerrAscend's corporate governance practices to other cannabis companies like Curaleaf, Green Thumb Industries, or Trulieve would require a more detailed analysis of their respective proxy statements and governance policies.

Stakeholder Impact

• Shareholders are directly impacted by the proposals being voted on, including the election of directors and the approval of executive compensation plans.
• Employees may be indirectly impacted by the decisions made at the annual meeting, as they can affect the company's overall strategy and performance.
• The company's performance and governance practices can also impact customers, suppliers, and creditors.

Next Steps

• Shareholders are encouraged to review the proxy materials and vote on the proposals.
• The annual meeting will be held on June 17, 2024, and shareholders can attend virtually.

Key Dates

Keywords

shareholder meeting, proxy statement, director election, stock options, MNP LLP, corporate governance, TerrAscend, cannabis industry